01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#TSP TruSpine Technologies PLC – Half-year Report December 30, 2025 – Posted in: Uncategorized

The Company continues to be in a pre-revenue development phase and remains loss-making.  The loss before taxation for the six months to 30 September 2025 was £335k (2024: £410k) after administrative expenses of £335k (2024: £410k). Consolidated net assets as at 30 September 2025 amounted to £1.83 million (2024: £2.33 million) including a bank balance of £33k as at 30 September 2025 (2024: £51k). As highlighted in recent shareholder communications, until discussions regarding the long-term…

Continue reading

#TSP TruSpine Technologies PLC – Final Results September 30, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems, reports its full year results for the year ended 29 March 2024.   The Company continues to be in a pre-revenue development phase and remains loss making at this stage of its development. The loss before taxation for the year was £702k (2023: £853k) after administrative expenses of £656k (2023: £846k). The R&D tax…

Continue reading

#TSP TruSpine Technologies PLC – Final Results September 29, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems, reports its full year results for the year ended 29 March 2023.   The Company continues to be in a pre-revenue development phase and remains loss making at this stage of its development. The loss before taxation for the year was £853k (2022: £941k) after administrative expenses of £846k (2022: £938k). The R&D tax…

Continue reading